Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Urinary Bladder Neoplasms × Exercise × Clear all

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 28 Neoplasms 13 Breast Neoplasms 12 Lymphoma 5 Sarcopenia 3 Prostatic Neoplasms 3 Polycystic Ovary Syndrome 3 Fatigue 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Malnutrition 2 Lung Neoplasms 2 Insulin Resistance 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Cardiovascular Diseases 2 Cardiotoxicity 2 Carcinoma, Non-Small-Cell Lung 2 Weight Cycling 1 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Recurrence 1

Interventions

Gemcitabine 18 pembrolizumab 16 Cisplatin 14 Magnetic Resonance Spectroscopy 13 Specimen Handling 11 Cystectomy 10 Docetaxel 7 enfortumab vedotin 6 Mitomycin 6 Standard of Care 5 Cystoscopy 5 Carboplatin 5 durvalumab 4 Transurethral Resection of Bladder 4 Radiotherapy 4 Practice Guidelines as Topic 4 sacituzumab govitecan 3 avelumab 3 Surveys and Questionnaires 3 Radiation 3 Nivolumab 3 Multiparametric Magnetic Resonance Imaging 3 Mitozytrex 3 tislelizumab 2 dehydroftorafur 2 cemiplimab 2 alvimopan 2 Therapeutic Uses 2 Surgical Procedures, Operative 2 Platinum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05715684 2023-03-22

Prehab

Dana-Farber Cancer Institute

Phase NA Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡